| Product Code: ETC9412268 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Prophylactic Vaccines Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Prophylactic Vaccines Market - Industry Life Cycle |
3.4 South Korea Prophylactic Vaccines Market - Porter's Five Forces |
3.5 South Korea Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 South Korea Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 South Korea Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 South Korea Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 South Korea Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 South Korea Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing diseases. |
4.2.2 Growing government initiatives and support for vaccination programs. |
4.2.3 Rising prevalence of infectious diseases in South Korea. |
4.3 Market Restraints |
4.3.1 High cost associated with developing and producing vaccines. |
4.3.2 Limited availability of vaccines for certain diseases. |
4.3.3 Vaccine hesitancy among a portion of the population. |
5 South Korea Prophylactic Vaccines Market Trends |
6 South Korea Prophylactic Vaccines Market, By Types |
6.1 South Korea Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 South Korea Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 South Korea Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 South Korea Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 South Korea Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 South Korea Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 South Korea Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 South Korea Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 South Korea Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 South Korea Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 South Korea Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 South Korea Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 South Korea Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 South Korea Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 South Korea Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 South Korea Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 South Korea Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 South Korea Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 South Korea Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 South Korea Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 South Korea Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 South Korea Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 South Korea Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 South Korea Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 South Korea Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 South Korea Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 South Korea Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 South Korea Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 South Korea Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 South Korea Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 South Korea Prophylactic Vaccines Market Export to Major Countries |
7.2 South Korea Prophylactic Vaccines Market Imports from Major Countries |
8 South Korea Prophylactic Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rates in target populations. |
8.2 Number of new vaccine introductions in the market. |
8.3 Research and development investment in new vaccine technologies. |
8.4 Public health campaigns promoting vaccination awareness. |
8.5 Number of reported cases of vaccine-preventable diseases in South Korea. |
9 South Korea Prophylactic Vaccines Market - Opportunity Assessment |
9.1 South Korea Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 South Korea Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 South Korea Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 South Korea Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 South Korea Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 South Korea Prophylactic Vaccines Market - Competitive Landscape |
10.1 South Korea Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 South Korea Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here